Business
Bell Potter just upgraded the target price on ASX healthcare stock
Image source: Getty Images
Broker Bell Potter has issued a new report on ASX healthcare stock Neuren Pharmaceuticals Ltd (ASX: NEU).
It has maintained its buy rating and also increased its target price.
Neuren Pharmaceuticals is a biopharmaceutical company specialising in developing new…
Continue Reading
-
General11 hours agoWA Police investigate death of baby in Baldivis in Perth’s southern suburbs
-
Noosa News22 hours agoAnna Creek Station owners charged for alleged illegal dams
-
Noosa News17 hours agoBrisbane bus driver found guilty over CBD crash that killed Tia Cameron
-
Noosa News16 hours agoBus driver found guilty over death of 18yo Tia Cameron